Sperm Cholesterol Content Modifies Sperm Function and TRPV1-Mediated Sperm Migration
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Transient receptor potential channels-vanilloid receptor 1 (TRPV1) regulates thermotaxis in sperm-oriented motility. We investigated the role of membrane cholesterol (Chol) on TRPV1-mediated human sperm migration. Semen samples were obtained from five normozoospemic healthy volunteers. Sperm membrane Chol content, quantified by liquid chromatography-mass spectrometry, was modified by incubating cells with 2-hydroxypropyl-ß-cyclodextrin (CD) or the complex between CD and Chol (CD:Chol). The effect on sperm migration on a 10 μM capsaicin gradient (CPS), a TRPV1 agonist, was then investigated. Motility parameters were evaluated by Sperm Class Analyser. Intracellular calcium concentration and acrosome reaction were measured by staining with calcium orange and FITC-conjugated anti-CD46 antibody, respectively. TRPV1-Chol interaction was modelled by computational molecular-modelling (MM). CD and CD:Chol, respectively, reduced and increased membrane Chol content in a dose-dependent manner, resulting in a dose-dependent increase and reduction of sperm migration in a CPS gradient. MM confirmed a specific interaction of Chol with a TRPV1 domain that appeared precluded to the Chol epimer epicholesterol (Epi-Chol). Accordingly, CD:Epi-Chol was significantly less efficient than CD:Chol, in reducing sperm migration under CPS gradient. Chol inhibits TRPV1-mediated sperm function by directly interacting with a consensus sequence of the receptor.
Mechanisms of oxidative stress-induced sperm dysfunction.
Wang Y, Fu X, Li H Front Endocrinol (Lausanne). 2025; 16:1520835.
PMID: 39974821 PMC: 11835670. DOI: 10.3389/fendo.2025.1520835.
Lipid remodeling in acrosome exocytosis: unraveling key players in the human sperm.
Suhaiman L, Belmonte S Front Cell Dev Biol. 2024; 12:1457638.
PMID: 39376630 PMC: 11456524. DOI: 10.3389/fcell.2024.1457638.
De Toni L, Cosci I, Sabovic I, Di Nisio A, Guidolin D, Pedrucci F Int J Mol Sci. 2023; 24(11).
PMID: 37298205 PMC: 10253330. DOI: 10.3390/ijms24119254.
Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs.
Chiarella E, Nistico C, Di Vito A, Morrone H, Mesuraca M Biomedicines. 2022; 10(5).
PMID: 35625883 PMC: 9138592. DOI: 10.3390/biomedicines10051146.